Table 3.
Prevalence estimates of MCI defined according to expanded Mayo Clinic criteria in major population-based studies
| Study | Location | Reference | n | Age (years) | Prevalence % |
|---|---|---|---|---|---|
| CHS | USA | Lopez et al. 2003 [17] | 1690 | ≥75 | 22.0 |
| EPESE | USA | Purser et al. 2005 [18] | 3673 | ≥65 | 24.7 |
| LEILA 75+ | Germany | Busse et al. 2006 [19] | 980 | 75–79 | 19.3 |
| Kolkata | India | Das et al. 2007 [20] | 745 | ≥50 | 14.9 |
| ILSA | Italy | Di Carlo et al. 2007 [21] | 2830 | 65–84 | 16.1 |
| KP | Sweden | Palmer et al. 2008 [22] | 379 | ≥75 | 11.1 |
| 3C | France | Artero 2008 et al. [23] | 6892 | ≥65 | 42.0 |
| Manhattan | USA | Manly 2008 et al. [24] | 2364 | ≥65 | 21.8 |
| ADAMS | USA | Plassman et al. 2008 [25] | 856 | ≥71 | 22.2 |
| Mayo | USA | Petersen et al. 2010 [26] | 1969 | 70–89 | 14.8 |
| CSBA | Italy | Ravaglia et al. 2008 [27] | 1016 | ≥65 | 7.7 |
| Tone Town | Japan | Sasaki et al. 2009 [28] | 1888 | ≥65 | 18.9 |
| MYHAT | USA | Ganguli et al. 2010 [29] | 2036 | ≥65 | 16.6 |
| HNR | Germany | Dlugaj et al. 2010 [30] | 4145 | 50–80 | 7.8 |
| South Korea | Korea | Kim et al. 2011 [31] | 1673 | ≥65 | 24.1 |
| MemoVie | Luxemburg | Perquin et al. 2012 [32] | 1377 | 65–70 | 20.0 |